1.
Emerg Infect Dis
; 24(8): 1594-1596, 2018 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30016251
RESUMO
Progressive multifocal leukoencephalopathy (PML) is increasingly being reported in patients undergoing immunotherapy. We report a case of progressive multifocal leukoencephalopathy after treatment with nivolumab, a PD-1 blocker that is used to restore impaired T-cell responses in patients with cancer and infections. Data for 4 other cases were obtained from pharmacovigilance databases.